Contribution of adiponectin to the cardiometabolic risk of postmenopausal women with loss-of-function lipoprotein lipase gene mutations

Menopause

Volumn 18, Issue 5, 2011, Pages 558-562

  Loucif, Yacine ^a   Méthot, Julie ^a   Tremblay, Karine ^a   Brisson, Diane ^a   Gaudet, Daniel ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Adiponectin; Lipoprotein lipase; Menopausal status

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; APOLIPOPROTEIN B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; METABOLISM; MULTIPLE REGRESSION; POSTMENOPAUSE; PROTEIN BLOOD LEVEL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CORONARY DISEASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LIPIDS; LIPOPROTEIN LIPASE; MIDDLE AGED; MUTATION; POSTMENOPAUSE; RISK; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 79960024793     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e3181fca1d4     Document Type: Article

References (41)

1. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996;37:693-707. (Pubitemid 26140808)
2. Kastelein JJ, Groenemeyer BE, Hallman DM, et al. The Asn9 variant of lipoprotein lipase is associated with the-93G promoter mutation and an increased risk of coronary artery disease. The Regress Study Group. Clin Genet 1998;53:27-33. (Pubitemid 28116117)
3. Saiki A, Oyama T, Endo K, et al. Preheparin serum lipoprotein lipase mass might be a biomarker of metabolic syndrome. Diabetes Res Clin Pract 2007;76:93-101. (Pubitemid 46240367)
4. Middelberg RP, Spector TD, Swaminathan R, Snieder H. Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol 2002;22:1142-1147. (Pubitemid 34764865)
5. Berg AH, Combs TP, Scherer PE. ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism. Trends Endocrinol Metab 2002;13:84-89. (Pubitemid 36740452)
6. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res 2005;96:939-949. (Pubitemid 40712793)
7. Maahs DM, Ogden LG, Kinney GL, et al. Low plasma adiponectin levels predict progression of coronary artery calcification. Circulation 2005;111:747-753. (Pubitemid 40250635)
8. Okamoto Y, Arita Y, Nishida M, et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 2000;32:47-50. (Pubitemid 30143606)
9. Yamamoto Y, Hirose H, Saito I, et al. Correlation of the adipocytederived protein adiponectin with insulin resistance index and serum highdensity lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clin Sci (Lond) 2002;103:137-142.
10. Bouhali T, Brisson D, St-Pierre J, et al. Low plasma adiponectin exacerbates the risk of premature coronary artery disease in familial hypercholesterolemia. Atherosclerosis 2008;196:262-269.
11. Chan DC, Watts GF, Ng TW, et al. Adiponectin and other adipocytokines as predictors of markers of triglyceride-rich lipoprotein metabolism. Clin Chem 2005;51:578-585. (Pubitemid 40300234)
12. Gaudet D, Tremblay G, Perron P, Gagne C, Ouadahi Y, Moorjani S. Familial hypercholesterolemia in eastern Quebec: a public health problem? The experience of the hyperlipidemia clinic of Chicoutimi. Union Med Can 1995;124:54-60.
13. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
14. Gaudet D, Vohl MC, Perron P, et al. Relationships of abdominal obesity and hyperinsulinemia to angiographically assessed coronary artery disease in men with known mutations in the LDL receptor gene. Circulation 1998;97:871-877. (Pubitemid 28113925)
15. Gaudet D, Arsenault S, Belanger C, et al. Procedure to protect confidentiality of familial data in community genetics and genomic research. Clin Genet 1999;55:259-264. (Pubitemid 29206194)
16. Warnick GR, Benderson J, Albers JJ. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-1388. (Pubitemid 12125081)
17. Chen Y, Zhang X, Pan B, et al. A modified formula for calculating lowdensity lipoprotein cholesterol values. Lipids Health Dis 2010;9:52.
18. Bijvoet SM, Hayden MR. Mismatch PCR: a rapid method to screen for the Pro207→Leu mutation in the lipoprotein lipase (LPL) gene. Hum Mol Genet 1992;1:541.
19. Ebara T, Endo Y, Yoshiike S, et al. A 60-y-old chylomicronemia patient homozygous for missense mutation (G188E) in the lipoprotein lipase gene showed no accelerated atherosclerosis. Clin Chim Acta 2007;386:100-104. (Pubitemid 47422323)
20. Mailly F, Tugrul Y, Reymer PW, et al. A common variant in the gene for lipoprotein lipase (Asp9→Asn). Functional implications and prevalence in normal and hyperlipidemic subjects. Arterioscler Thromb Vasc Biol 1995;15:468-478.
21. Zhang H, Reymer PW, Liu MS, et al. Patients with apoE3 deficiency (E2/2, E3/2, and E4/2) who manifest with hyperlipidemia have increased frequency of an Asn 291→Ser mutation in the human LPL gene. Arterioscler Thromb Vasc Biol 1995;15:1695-1703.
22. Henneman P, Janssens AC, Zillikens MC, et al. Menopause impacts the relation of plasma adiponectin levels with the metabolic syndrome. J Intern Med 2010;267:402-409.
23. Hokanson JE. Lipoprotein lipase gene variants and risk of coronary disease: a quantitative analysis of population-based studies. Int J Clin Lab Res 1997;27:24-34.
24. Wittrup HH, Tybjaerg-Hansen A, Abildgaard S, Steffensen R, Schnohr P, Nordestgaard BG. A common substitution (Asn291Ser) in lipoprotein lipase is associated with increased risk of ischemic heart disease. J Clin Invest 1997;99:1606-1613. (Pubitemid 27163811)
25. Clee SM, Loubser O, Collins J, Kastelein JJ, Hayden MR. The LPL S447X cSNP is associated with decreased blood pressure and plasma triglycerides, and reduced risk of coronary artery disease. Clin Genet 2001;60:293-300. (Pubitemid 33019514)
26. Rip J, Nierman MC, Ross CJ, et al. Lipoprotein lipase S447X: a naturally occurring gain-of-function mutation. Arterioscler Thromb Vasc Biol 2006;26:1236-1245. (Pubitemid 44305366)
27. Fujiwara S, Kotani K, Sano Y, et al. S447X polymorphism in the lipoprotein lipase gene and the adiponectin level in the general population: results from the MIMA study. J Atheroscler Thromb 2009;16:188-193.
28. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-2769. (Pubitemid 34655342)
29. Hulthe J, Hulten LM, Fagerberg B. Low adipocyte-derived plasma protein adiponectin concentrations are associated with the metabolic syndrome and small dense low-density lipoprotein particles: atherosclerosis and insulin resistance study. Metabolism 2003;52:1612-1614. (Pubitemid 38049281)
30. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 2001;7:941-946. (Pubitemid 32756432)
31. Qiao L, Zou C, van der Westhuyzen DR, Shao J. Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes 2008;57:1824-1833.
32. Levak-Frank S, Hofmann W, Weinstock PH, et al. Induced mutant mouse lines that express lipoprotein lipase in cardiac muscle, but not in skeletal muscle and adipose tissue, have normal plasma triglyceride and highdensity lipoprotein-cholesterol levels. Proc Natl Acad Sci U S A 1999;96:3165-3170. (Pubitemid 29148862)
33. von Eynatten M, Schneider JG, Humpert PM, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 2004;27:2925-2929. (Pubitemid 39565060)
34. De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP. Postheparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects. Clin Lab 2005;51:403-409. (Pubitemid 41179674)
35. Kobayashi J, Kusunoki M, Murase Y, et al. Relationship of lipoprotein lipase and hepatic triacylglycerol lipase activity to serum adiponectin levels in Japanese hyperlipidemic men. Horm Metab Res 2005;37:505-509. (Pubitemid 41306401)
36. Mattei MG, Etienne J, Chuat JC, et al. Assignment of the human lipoprotein lipase (LPL) gene to chromosome band 8p22. Cytogenet Cell Genet 1993;63:45-46. (Pubitemid 23102321)
37. Cho GJ, Lee JH, Park HT, et al. Postmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524-529.
38. Gupta P, Harte A, Sturdee DW, et al. Effects of menopausal status on circulating calcitonin gene-related peptide and adipokines: implications for insulin resistance and cardiovascular risks. Climacteric 2008;11:364-372.
39. Manigrasso MR, Ferroni P, Santilli F, et al. Association between circulating adiponectin and interleukin-10 levels in android obesity: effects of weight loss. J Clin Endocrinol Metab 2005;90:5876-5879. (Pubitemid 41415505)
40. Gable DR, Matin J, Whittall R, et al. Common adiponectin gene variants show different effects on risk of cardiovascular disease and type 2 diabetes in European subjects. Ann Hum Genet 2007;71:453-466. (Pubitemid 46865494)
41. Santos JL, Boutin P, Verdich C, et al. Genotype-by-nutrient interactions assessed in European obese women. A case-only study. Eur J Nutr 2006;45:454-462. (Pubitemid 46020596)